{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:30:26Z","timestamp":1793068226487,"version":"4.5.0"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jdcr.2023.02.021","type":"journal-article","created":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T03:15:29Z","timestamp":1678331729000},"page":"5-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Hair regrowth in endocrine therapy alopecia with dutasteride treatment in woman with estrogen positive breast cancer"],"prefix":"10.1016","volume":"35","author":[{"given":"Celina","family":"Dubin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jdcr.2023.02.021_bib1","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/jamadermatol.2018.0454","article-title":"Endocrine therapy-induced alopecia in patients with breast cancer","volume":"154","author":"Freites-Martinez","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.jdcr.2023.02.021_bib2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.5301\/tj.5000376","article-title":"Adjuvant aromatase inhibitor therapy in early breast cancer: what factors lead patients to discontinue treatment?","volume":"101","author":"Moscetti","year":"2015","journal-title":"Tumori J"},{"issue":"6","key":"10.1016\/j.jdcr.2023.02.021_bib3","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1001\/jamadermatol.2018.0453","article-title":"Minoxidil for endocrine therapy\u2013induced alopecia in women with breast cancer\u2014Saint Agatha's Blessing?","volume":"154","author":"Tr\u00fceb","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jdcr.2023.02.021_bib4","unstructured":"First FDA-Approved, Once Daily Application 5% Minoxidil Formula for Women Hits the Market [Press Release]. PR Newswire; 2014."},{"issue":"5","key":"10.1016\/j.jdcr.2023.02.021_bib5","first-page":"637","article-title":"Effective treatment of female androgenic alopecia with dutasteride","volume":"4","author":"Olszewska","year":"2005","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"10.1016\/j.jdcr.2023.02.021_bib6","doi-asserted-by":"crossref","first-page":"521","DOI":"10.4103\/0378-6323.144162","article-title":"The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia","volume":"80","author":"Boersma","year":"2014","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"8-9","key":"10.1016\/j.jdcr.2023.02.021_bib7","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0531-5565(02)00093-1","article-title":"Molecular mechanisms of androgenetic alopecia","volume":"37","author":"Tr\u00fceb","year":"2002","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.jdcr.2023.02.021_bib8","first-page":"1577","article-title":"Long-term use of 5\u03b1-reductase inhibitors and the risk of male breast cancer","volume":"25","author":"Duijnhoven","year":"2014","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.jdcr.2023.02.021_bib9","first-page":"1289","article-title":"5-\u03b1 reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer","volume":"26","author":"Robinson","year":"2015","journal-title":"Cancer Causes Control"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512623000784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512623000784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:25:46Z","timestamp":1762475146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512623000784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":9,"alternative-id":["S2352512623000784"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2023.02.021","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hair regrowth in endocrine therapy alopecia with dutasteride treatment in woman with estrogen positive breast cancer","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2023.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}